NeuroTechnology Investors
Palo Alto, Californiathemdadvantage.com
Overview
NeuroTechnology Investors (NTI) is a global investor network of physicians that identifies, invests in, and provides operational expertise to emerging medical technology companies. The group states it is not a traditional fund, but an investment vehicle in which physicians retain control and invest their clinical expertise alongside capital to accelerate development. It focuses on neuro-focused companies and other advancements in the medical device and digital health sectors.
Portfolio Companies
6
Website
themdadvantage.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Radical Catheter Technologies | Jul 2024 | VC Round | Lead |
| Basecamp Vascular | Dec 2023 | Series A | Co-investor |
| Let's Get Proof | May 2023 | Early Funding | Lead |
| Synchron | Dec 2022 | Series C | Co-investor |
| Syncfony | Dec 2022 | Series C | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
